Data from 342 consecutive early RA patients participating in the ‘Parelsnoer’ cohort showed that suppressing inflammation (demonstrated by a decrease in ESR or CRP), independently of achieving remission, increases sRAGE levels significantly. This evidence concerns the gene CRP and rheumatoid arthritis.